Burn wound management requires multifunctional dressings that can simultaneously maintain a moist healing environment, provide localized analgesia, and prevent microbial colonization. In this study, an advanced bilayer hydrocolloid dressing was developed by integrating a pectin–PVA–lidocaine (LDC) lower layer for immediate pain management with a chitosan–gelatin–vancomycin (VH) upper layer for sustained antibacterial protection. The physicochemical properties and intermolecular interactions of the bilayer hydrocolloid dressing were comprehensively characterized using FTIR, XRD, DSC/TGA, SEM, and XPS analyses. Swelling and degradation assays demonstrated that the hybrid films possess high fluid‐handling capacity (reaching 309% swelling). Mechanical characterization showed superior durability with a tensile strength of 50.8 MPa and 63% elongation at break. In vitro studies confirmed a synchronized biphasic release profile for both LDC and VH, following a Quasi‐Fickian diffusion mechanism. Biological assessments using L929 fibroblasts showed high cytocompatibility (viability > 125%), while antibacterial assays demonstrated robust inhibition against S. aureus and E. coli . These findings suggest that the dual‐layered hybrid architecture provides a clinically relevant, synergistic platform for the next generation of advanced burn wound treatments.
No takes yet. Share an insight, caveat, or question.
Akkad et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: